Joint Workshop hosted by
Health Canada
and
Canadian Society for Pharmaceutical Sciences (CSPS)

The objective of the workshop will be to advance education and dialog among stakeholders about frontiers in clinical development and regulatory/HTA decision making for early stage cancers. The program (in development) will include presentations and panel discussions about clinical trial endpoints, opportunities and challenges in establishing endpoint surrogacy, regulatory and HTA decision making, and patient voice.